Maravai Lifesciences Holdings Inc (MRVI)
R&D Expense Growth
-4.81%
Quarterly · Period ending:
MRVI R&D Expense Growth
Latest reported-4.81%period ending
Latest reported-4.81%period ending
MRVI Quarterly R&D Growth (QoQ) (0.00% → -4.81%)
Latest values, visible window
High-resolution chart · PNG
MRVI r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -4.8084% | |
| 2.6663% | |
| -61.2282% | |
| 100.1229% | |
| -0.1227% | |
| 7.1695% | |
| 4.9954% | |
| -17.7896% | |
| 5.0079% | |
| 9.5342% | |
| 5.6821% | |
| 3.6481% | |
| 1.1821% | |
| -17.282% | |
| -7.0143% | |
| 26.088% | |
| 15.6698% | |
| -59.7187% | |
| 371.3772% | |
| 0.8813% | |
| -10.6944% | |
| 3.2505% | |
| 11.9914% | |
| 16.75% | |
| -57.265% | |
| 282.4311% | |
| 0% |